Propanc Biopharma, Inc. (PPCB )

Currency in USD Disclaimer
$1.35 $0 (0%)
Closed 08/31/2026
$1.25
$1.48
$0.95
$86.14

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

  • Symbol PPCB
  • Company Propanc Biopharma, Inc.
  • Price $1.35
  • Changes Percentage 0
  • Change 0
  • Day Low $1.25
  • Day High $1.48
  • Year High $86.14
  • Year Low $0.95
  • Market Cap $2,460,641
  • Price Avg 50 EMA (D) $1.45
  • Price Avg 200 EMA (D) $6.75
  • Exchange NASDAQ
  • Volume 25,110
  • Average Volume 3,928,119
  • Open $1.28
  • Previous Close $1.35
  • EPS -8.04
  • PE -0.13
  • Earnings Announcement 2026-05-14 21:30:07
  • Shares Outstanding $2,278,371

Company brief: PROPANC BIOPHARMA, INC. (PPCB )

Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. The company has a research collaboration with University of Jaén to commence the POP1 joint drug discovery program. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.

PPCB Corporation News

Income Statement